Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Sarcoma and BRCA2[original query] |
|---|
| Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast cancer research : BCR 2012 14 (2): R66. Lee Daphne S C, Yoon Sook-Yee, Looi Lai Meng, Kang Peter, Kang In Nee, Sivanandan Kavitta, Ariffin Hany, Thong Meow Keong, Chin Kin Fah, Mohd Taib Nur Aishah, Yip Cheng-Har, Teo Soo-Hwa |
| Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations. Breast cancer research and treatment 2013 Jul 140 (1): 207-11. Kadouri Luna, Sagi Michal, Goldberg Yael, Lerer Israela, Hamburger Tamar, Peretz Tam |
| The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS genetics 2014 Jul 10 (7): e1004475. Brohl Andrew S, Solomon David A, Chang Wendy, Wang Jianjun, Song Young, Sindiri Sivasish, Patidar Rajesh, Hurd Laura, Chen Li, Shern Jack F, Liao Hongling, Wen Xinyu, Gerard Julia, Kim Jung-Sik, Lopez Guerrero Jose Antonio, Machado Isidro, Wai Daniel H, Picci Piero, Triche Timothy, Horvai Andrew E, Miettinen Markku, Wei Jun S, Catchpool Daniel, Llombart-Bosch Antonio, Waldman Todd, Khan Jav |
| TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
| Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma. Cancer biology & therapy 2016 Oct 17 (10): 1017-1021. Miolo Gianmaria, Viel Alessandra, Canzonieri Vincenzo, Baresic Tania, Buonadonna Angela, Santeufemia Davide Adriano, Lara Della Puppa, Corona Giusep |
| Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas. Scientific reports 2017 9 7 (1): 10660. Chan Sock Hoai, Lim Weng Khong, Ishak Nur Diana Binte, Li Shao-Tzu, Goh Wei Lin, Tan Gek San, Lim Kiat Hon, Teo Melissa, Young Cedric Ng Chuan, Malik Simeen, Tan Mann Hong, Teh Jonathan Yi Hui, Chin Francis Kuok Choon, Kesavan Sittampalam, Selvarajan Sathiyamoorthy, Tan Patrick, Teh Bin Tean, Soo Khee Chee, Farid Mohamad, Quek Richard, Ngeow Joan |
| Breast cancer cases of female patients under 35 years of age in Togo: A series of 158 cases. Molecular and clinical oncology 2017 12 7 (6): 1125-1129. Darré Tchin, Tchaou Mazamaesso, Folligan Koué, Amadou Abdoulatif, N'Timon Bidamin, Sonhaye Lantam, Aboubakari Abdoul-Samadou, Amégbor Koffi, Akpadza Koffi, Napo Koura Ga |
| Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers. Cancer 2019 Mar 125 (5): 698-703. Laitman Yael, Michaelson-Cohen Rachel, Levi Einat, Chen-Shtoyerman Rakefet, Reish Orit, Josefsberg Ben-Yehoshua Sagi, Bernstein-Molho Rinat, Keinan-Boker Lital, Rosengarten Ora, Silverman Barbara G, Perri Tamar, Korach Jacob, Mor Pnina, Ephrat Ben-Baruch Noa, Levy Lahad Ephrat, Friedman Eitan, |
| Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas. International journal of clinical oncology 2019 May . Liang Xiaohong, Li Qing, Xu Bin, Hu Song, Wang Qianyun, Li Yan, Zong Yun, Zhang Sujuan, Li Cho |
| Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 4 26 (14): 3881-3888. Hensley Martee L, Chavan Shweta S, Solit David B, Murali Rajmohan, Soslow Robert, Chiang Sarah, Jungbluth Achim A, Bandlamudi Chaitanya, Srinivasan Preethi, Tap William D, Rosenbaum Evan, Taylor Barry S, Donoghue Mark T A, Hyman David |
| Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer. International journal of radiation oncology, biology, physics 2020 2 107 (2): 353-359. Schlosser Shir, Rabinovitch Rachel, Shatz Zina, Galper Shira, Shahadi-Dromi Ilanit, Finkel Sara, Jacobson Galia, Rasco Adi, Friedman Eitan, Laitman Yael, Evron Ella, Bernstein Rinat, Weiss Ilana, Sklair-Levy Miri, Ben-David Merav |
| The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors. Journal of cancer research and clinical oncology 2021 Sep . Kim Hana, Ahn Soomin, Kim Hongsik, Hong Jung Yong, Lee Jeeyun, Park Se Hoon, Park Joon Oh, Park Young Suk, Lim Ho Yeong, Kang Won Ki, Kim Kyoung-Mee, Kim Seung T |
| Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. JCO precision oncology 2021 5 . Kim Jung, Light Nicholas, Subasri Vallijah, Young Erin L, Wegman-Ostrosky Talia, Barkauskas Donald A, Hall David, Lupo Philip J, Patidar Rajesh, Maese Luke D, Jones Kristine, Wang Mingyi, Tavtigian Sean V, Wu Dongjing, Shlien Adam, Telfer Frank, Goldenberg Anna, Skapek Stephen X, Wei Jun S, Wen Xinyu, Catchpoole Daniel, Hawkins Douglas S, Schiffman Joshua D, Khan Javed, Malkin David, Stewart Douglas |
| Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
| Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer. Frontiers in genetics 2022 12 13 1026871. Wu Xin, Wang Qiong, Liu Peifa, Sun Linde, Wang |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: